The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy

INTRODUCTION: The classification of patients with prostate cancer is used to determine treatments based on risk factors. The presence of secondary circulating prostate tumour cells (CPCs) detected in peripheral blood after a curative treatment has been associated with a worse prognosis. We present a...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, Nigel P, Aedo, Socrates, Fuentealba, Cynthia, Reyes, Eduardo, Minzer, Simone, Salazar, Aníbal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027969/
https://www.ncbi.nlm.nih.gov/pubmed/30034521
http://dx.doi.org/10.3332/ecancer.2018.844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027969/
https://www.ncbi.nlm.nih.gov/pubmed/30034521
http://dx.doi.org/10.3332/ecancer.2018.844

Ejemplares similares